[1]
“A retrospective evaluation of therapeutic efficacy and safety of chemoradiotherapy in older patients (aged ≥ 75 years) with limited-disease small cell lung cancer: Insights from two institutions: Chemoradiotherapy in older patients with limited-disease small cell lung cancer”, Radiol Oncol, vol. 58, no. 3, pp. 432–443, Sep. 2024, Accessed: Sep. 24, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/4269